A Multicenter, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Investigate the Use of Benralizumab for Eosinophilic Esophagitis

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2020
This article has no abstract
Epistemonikos ID: c13975e7651a99988b851c7a0c9edbbb4d469296
First added on: Apr 11, 2025